2018 Dosage Pharmaceutical Companies 
Express Pharma
APRIL 7, 2025
Fixed-dose combinations (FDCs), which contain two or more active ingredients in a single dosage form, have seen a significant rise in production and usage across the pharmaceutical industry. Additionally, pharmaceutical companies have increasingly turned to FDCs as a way to differentiate their products in a highly competitive market.
pharmaphorum
JUNE 1, 2021
Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients. Instant verification at the dosage level reduces the risk of counterfeiting and product diversion while facilitating quality control and returns monitoring. About the author . appeared first on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 6, 2022
Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceutical companies to develop drugs with improved efficiency and efficacy. Nowadays, you have drugs against cancer which have a very high impact even at a very low dosage.”.
PharmaState Academy
MAY 16, 2023
While Big Pharma sees its R&D share drop, emerging life science companies are better prepared to go it alone,” says a an interesting report from Fierce Biotech (1) The report further says that 2018 was a bumper year for FDA approvals, with 59 new therapies getting the thumbs-up. PFS’s reduce dosing errors and accuracy is high.
European Pharmaceutical Review
AUGUST 23, 2022
2 The global counterfeit pharmaceuticals trade is estimated to be worth billions annually, 3 bolstered significantly by the increased illicit online pharmacies that emerged during the COVID-19 pandemic. Bitter Pills: The Global War on Counterfeit Drugs: Oxford University Press; 2018. References. 2019; Available from: [link].
pharmaphorum
DECEMBER 15, 2020
There is a long-established synergistic relationship between larger, “innovation-driven” pharmaceutical companies and the generics industry in ensuring supply of established, but nevertheless essential, medicines. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies.
Pharmaceutical Technology
SEPTEMBER 26, 2022
Sandoz has a strong global brand and a unique heritage in areas ranging from generic antibiotics to biosimilars; it is also determined to differentiate itself as the off-patent company with the greatest focus on identifying and meeting patient needs.”. The company had revenues of $9.6bn both in 2020 and last year.
Expert insights. Personalized for you.
65 
Let's personalize your content